CEMIPLIMAB

cemiplimab 350 mg/7 mL injection, 7 mL vial

CEMIPLIMAB (13169D)

cemiplimab 350 mg/7 mL injection, 7 mL vial
13169D
Body System:
Manner of administration:Injection
Public
Chemotherapy Items for Public Hospital use
Authority Required (STREAMLINED)

Restriction  18455

Indication: Stage IV (metastatic) non-small cell lung cancer (NSCLC)
Treatment phase: Initial treatment - 3 weekly treatment regimen
Quantities & Cost
Max amount # of repeats DPMA Max safety net General Patient Charge
Max amount: 350 mg # of repeats: 6 DPMA: $7,381.23 Max safety net: $25.00 General Patient Charge: $25.00
Available brands
Libtayo
(cemiplimab 350 mg/7 mL injection, 7 mL vial)